Saturna Capital Corp Immutep LTD Transaction History

Saturna Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.96 - $3.09 $127,400 - $200,850	-65,000 Reduced 76.02%	20,500 $42,000
Q1 2022 May 10, 2022	SELL	$2.3 - $3.61 $18,400 - $28,880	-8,000 Reduced 8.56%	85,500 $234,000
Q4 2021 Feb 09, 2022	BUY	$3.09 - $4.81 $3,090 - $4,810	1,000 Added 1.08%	93,500 $307,000
Q3 2021 Nov 08, 2021	BUY	$3.17 - $4.39 $9,510 - $13,169	3,000 Added 3.35%	92,500 $358,000
Q2 2021 Aug 11, 2021	BUY	$3.02 - $5.21 $270,290 - $466,295	89,500 New	89,500 $346,000

1.86M

264K

90.5K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $172M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Saturna Capital Corp with notifications on news.